Jazz Pharmaceuticals plc (J7Z) - Total Liabilities

Latest as of March 2026: €7.33 Billion EUR ≈ $8.57 Billion USD

Based on the latest financial reports, Jazz Pharmaceuticals plc (J7Z) has total liabilities worth €7.33 Billion EUR (≈ $8.57 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Jazz Pharmaceuticals plc net asset momentum to track the company's year-over-year net asset growth rate.

Jazz Pharmaceuticals plc - Total Liabilities Trend (2013–2025)

This chart illustrates how Jazz Pharmaceuticals plc's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Jazz Pharmaceuticals plc to measure how efficiently the company converts operating cash flow to free cash.

Jazz Pharmaceuticals plc Competitors by Total Liabilities

The table below lists competitors of Jazz Pharmaceuticals plc ranked by their total liabilities.

Company	Country	Total Liabilities
Penske Automotive Group Inc NYSE:PAG	USA	$12.64 Billion
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	USA	$656.90 Million
Focus Media Information Technology Co Ltd SHE:002027	China	CN¥6.96 Billion
Ningbo Tuopu Group Co Ltd SHG:601689	China	CN¥16.95 Billion
Alamos Gold Inc TO:AGI	Canada	CA$1.94 Billion
AB SKF (publ) ST:SKF-B	Sweden	Skr52.19 Billion
Dynatrace Holdings LLC NYSE:DT	USA	$1.80 Billion
Krung Thai Bank Public Company Limited F:NVPB	Germany	€3.35 Trillion

Liability Composition Analysis (2013–2025)

This chart breaks down Jazz Pharmaceuticals plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see J7Z stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.04	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.62	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.62	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jazz Pharmaceuticals plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jazz Pharmaceuticals plc (2013–2025)

The table below shows the annual total liabilities of Jazz Pharmaceuticals plc from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	€7.34 Billion ≈ $8.58 Billion	-7.30%
2024-12-31	€7.92 Billion ≈ $9.26 Billion	+3.42%
2023-12-31	€7.66 Billion ≈ $8.95 Billion	-1.20%
2022-12-31	€7.75 Billion ≈ $9.06 Billion	-7.01%
2021-12-31	€8.33 Billion ≈ $9.74 Billion	+189.74%
2020-12-31	€2.88 Billion ≈ $3.36 Billion	+18.46%
2019-12-31	€2.43 Billion ≈ $2.84 Billion	-0.74%
2018-12-31	€2.45 Billion ≈ $2.86 Billion	+1.47%
2017-12-31	€2.41 Billion ≈ $2.82 Billion	-17.53%
2016-12-31	€2.92 Billion ≈ $3.42 Billion	+68.57%
2015-12-31	€1.73 Billion ≈ $2.03 Billion	-11.88%
2014-12-31	€1.97 Billion ≈ $2.30 Billion	+108.74%
2013-12-31	€942.69 Million ≈ $1.10 Billion	--

About Jazz Pharmaceuticals plc

F:J7Z Germany Biotechnology

Market Cap

$16.38 Billion

€14.01 Billion EUR

Market Cap Rank

#1949 Global

#407 in Germany

Share Price

€223.30

Change (1 day)

+0.59%

52-Week Range

€90.68 - €225.10

All Time High

€225.10